Its unknown if the peptide can lead to acne, water retention, hair loss, headaches, fatigue, or lethargy
Recalls & Warnings April 16, 2019 DMHA and Phenibut Are Not Permitted in Dietary Supplements, Warns FDA On April 16, 2019, the FDA announced it has issued 11 warning letters to companies whose dietary supplement products contain the drugs DMHA or phenibut, and therefore are in violation of the law
US National Library of Medicine
Supplying both as a single lyophilised vial reduces reconstitution steps for combined-protocol studies
This raises a theoretical concern about hypoglycemia when combined with insulin, sulfonylureas, or other glucose-lowering agents
Manufactured under strict quality standards with full batch traceability